Richard Johnson founded Upperton Pharma Solutions in August 1999, and continues to play a key role in the management and strategic development of the company. With over 30 years of experience in the pharmaceutical, biotechnology and drug delivery fields, Dr Johnson previously held senior management positions at Andaris Limited (Vectura) and Delta Biotechnology (now Albumedix, Nottingham, UK). Dr Johnson holds an
honours degree in Biology from University of York (UK) and a PhD from the University of Warwick (UK) and has a proven track record in successfully developing innovative pharmaceutical products from early feasibility studies through to commercial products.

More contributions